Lawrence Saperstein, MD

home / authors / lawrence-saperstein-md

Articles

The Future of Prostate Cancer Imaging

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 25th 2022

Prostate cancer experts highlight some closing thoughts and exciting research in progress on prostate cancer imaging.

Prostate Cancer Imaging: the VISION Trial

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 25th 2022

Neal Shore, MD, FACS, reviews the VISION clinical trial in prostate cancer imaging.

Patient Profile 7: Gleason 7 Prostate Cancer

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 25th 2022

A look at the patient profile of a 62-year-old man presenting with reduced urinary flow and hematuria.

Patient Profile 6: Robotic Radical Prostatectomy for Adenocarcinoma

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 18th 2022

Dr Steven Finkelstein explains a clinical example of a 65-year-old patient with a history of robotic radical prostatectomy for Gleason 9 adenocarcinoma.

Patient Profile 5: IMRT for Adenocarcinoma

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 18th 2022

Dr Lawrence Saperstein describes the patient profile of a 78-year-old man with a history of intensity-modulated radiation therapy for adenocarcinoma.

Prostate Cancer Imaging: the CONDOR Trial

Neal Shore, MD, FACS;Steven Finkelstein, MD, DABR, FACRO;Michael Gorin, MD;Lawrence Saperstein, MD

May 11th 2022

Key opinion leaders review the CONDOR clinical trial studying PSMA PET scans for prostate cancer imaging.

Patient Profile 4: Recurrent Prostate Cancer

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 11th 2022

Michael Gorin, MD, presents a clinical example of a 60-year-old patient with recurrent prostate cancer.

Bone Scans for Prostate Cancer Imaging

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 5th 2022

A panel of experts review whether bone scans still have a place in prostate cancer imaging.

Patient Profile 3: High-Risk Prostate Cancer

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

May 5th 2022

Steven Finkelstein, MD, DABR, FACRO, presents a high-risk prostate cancer patient profile for a 74-year-old man with a history of chronic prostatitis.

Patient Profile 2: High-Risk Prostate Cancer

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 29th 2022

Lawrence Saperstein, MD, reviews the patient profile of a 65-year-old man with high-risk prostate cancer.

The Role for PSMA PET Imaging in Prostate Cancer Monitoring

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 29th 2022

A look at how PSMA PET imaging fits into the monitoring of a patient with prostate cancer.

Discussing Treatments with Patients Based on Prostate Cancer Imaging

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 20th 2022

A radiation oncologist explains how to discuss the interpretation of prostate cancer imaging with patients in deciding on a treatment plan.

Visual Analysis vs SUV for Prostate Cancer Imaging

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 20th 2022

Dr Lawrence Saperstein describes the importance of coronal images and visual analysis in making a thoughtful treatment plan for prostate cancer.

Key Messages from the OSPREY Trial

Michael Gorin, MD;Neal Shore, MD, FACS;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 19th 2022

Authors from the OSPREY clinical trial highlight the key take-home messages from the trial outcomes.

Prostate Cancer Imaging: the OSPREY Trial

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 19th 2022

Key opinion leaders review the OSPREY clinical trial studying PSMA PET scans for prostate cancer imaging.

Patient Profile 1: High-Risk Localized Prostate Cancer

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 8th 2022

Doctors present the patient profile of a 66-year-old man with high-risk localized prostate cancer.

The Learning Curve of PSMA PET Scans

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 8th 2022

Michael Gorin, MD, describes his experiences with prostate cancer imaging both in academia and community-based practices.

The Multidisciplinary Approach to Prostate Cancer Management

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

April 1st 2022

An explanation of the importance of clinical providers following a multidisciplinary approach for prostate cancer management.

PSMA PET Clinical Trials

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

March 31st 2022

Experts review ongoing clinical trials in PSMA PET technology.

PSMA PET Scans for Prostate Cancer Imaging

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

March 23rd 2022

The panel explains the science behind PSMA PET scans and reviews the different positron-emitters used in the scans.

Rapid Advances in Prostate Cancer Imaging

Neal Shore, MD, FACS;Michael Gorin, MD;Steven Finkelstein, MD, DABR, FACRO;Lawrence Saperstein, MD

March 23rd 2022

A background on the available options and recent advances in prostate cancer imaging.

Latest Updated Articles

Published: December 23rd 2024 | Updated: January 23rd 2025

Bone Predominant mCRPC Patient Case

Published: May 7th 2024 | Updated: May 21st 2024

FDA accepts BLA for subcutaneous nivolumab in solid tumors

Doctor giving a consultation to a patient and explaining medical informations and diagnosis | © Pcess609 - stock.adobe.com

Published: April 22nd 2025 | Updated: May 25th 2025

Upper tract urothelial carcinoma: Key considerations and patient cases

Closeup financial chart with uptrend line candlestick graph in stock market on blue color monitor background | Image Credit: © iamchamp - stock.adobe.com

Published: March 21st 2025 | Updated: May 25th 2025

Money Matters: How to cope with market volatility in 2025

Published: March 27th 2025 | Updated: May 25th 2025

NeuroSAFE procedure for RARP leads to improved erectile function

Published: March 21st 2025 | Updated: May 25th 2025

Avoidance of prostate cancer screening linked to increased risk of PCSM